{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-197921","form_type":"8-K","ticker":"DBVT","cik":"0001613780","company_name":"DBV Technologies S.A.","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.593269+00:00","generated_at":"2026-05-15T00:57:23.616013+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DBV Technologies reports Q1 net loss of $47.6M; cash of $229M into Q2 2027","bullets":["Net loss of $47.6M ($0.11 per share) vs $27.1M ($0.26) in Q1 2025; loss per share improved due to equity base from PIPE.","Cash and cash equivalents $229M as of March 31, 2026, up from $194M at year-end 2025; funding into Q2 2027.","R&D expenses rose to $33.4M (from $21.5M) driven by COMFORT Toddlers study, BLA readiness, and pre-commercial inventory build.","SG&A expenses increased to $10.5M (from $5.6M) as company builds U.S. commercial infrastructure ahead of potential launch.","BLA submission for VIASKIN Peanut Patch (ages 4-7) planned H1 2026; toddler BLA H2 2026; Phase 2 THRIVE study in infants planned."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-197921","json":"https://secwatch.observer/filing/0001193125-26-197921.json","markdown":"https://secwatch.observer/filing/0001193125-26-197921.md","text":"https://secwatch.observer/filing/0001193125-26-197921.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613780/000119312526197921/0001193125-26-197921-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613780/000119312526197921/d132063d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:57:23.616013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad4227f46f5286922f26d36164fcf1bd167f366a","claim":"DBV Technologies S.A. reported the three months ended March 31, 2026 results: net income $47.6 million, EPS $(0.11).","evidence_excerpt":"Net loss was $47.6 million for the three months ended March 31, 2026","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613780/000119312526197921/0001193125-26-197921-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2026"},{"label":"Net income","value":"$47.6 million"},{"label":"EPS","value":"$(0.11)"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}